Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
| Data | Nome del titolare | Azioni transazionate | Intervallo di valore ($) | Tipo di transazione | Intervallo di prezzo ($) | Azioni a fine dichiarazione | % di variazione |
|---|---|---|---|---|---|---|---|
| 2026-05-15 | Mr. Douglas E. ColtharpExec. VP & CFO | -27,69k | 2,05M | Derivative Exercise and Sale | 32,94 - 107,28 | 260,24k | - |
| 2026-05-11 | Mr. Patrick W. TuerExec. VP & COO | -682,00 | 71,31k | Vendita | 104,56 | 24,76k | -2,68% |
| 2026-03-09 | Mr. Edmund M. FaySenior VP & Treasurer | -11,94k | 1,28M | Vendita | 107,00 | 86,33k | -12,15% |
| 2026-03-09 | Mr. Edmund M. FaySenior VP & Treasurer | -3,00k | 0,00 | Other Disposition | - | 86,33k | -3,36% |
| 2026-02-28 | Mr. Andrew L. PriceSenior VP & CAO | -307,00 | 33,12k | Sale to Issuer | 107,88 | 74,69k | -0,41% |
| 2026-02-28 | Mr. Edmund M. FaySenior VP & Treasurer | -280,00 | 30,21k | Sale to Issuer | 107,88 | 101,26k | -0,28% |
| 2026-02-28 | Dr. Elissa Joy CharbonneauChief Medical Officer | -369,00 | 39,81k | Sale to Issuer | 107,88 | 17,64k | -2,05% |
| 2026-02-28 | Mr. John Patrick DarbyExec. VP, General Counsel & Corporate Secretary | -416,00 | 44,88k | Sale to Issuer | 107,88 | 83,95k | -0,49% |
| 2026-02-28 | Mr. Mark J. TarrCEO, President & Director | -2,19k | 235,93k | Sale to Issuer | 107,88 | 440,96k | -0,49% |
| 2026-02-28 | Mr. Patrick W. TuerExec. VP & COO | -545,00 | 58,79k | Sale to Issuer | 107,88 | 25,44k | -2,10% |
| 2026-02-28 | Mr. Douglas E. ColtharpExec. VP & CFO | -776,00 | 83,71k | Sale to Issuer | 107,88 | 260,24k | -0,30% |
| 2026-02-23 | Mr. Mark J. TarrCEO, President & Director | -2,49k | 264,10k | Sale to Issuer | 106,15 | 443,15k | -0,56% |
| 2026-02-23 | Mr. Edmund M. FaySenior VP & Treasurer | -380,00 | 40,34k | Sale to Issuer | 106,15 | 101,54k | -0,37% |
| 2026-02-23 | Mr. Patrick W. TuerExec. VP & COO | -506,00 | 53,71k | Sale to Issuer | 106,15 | 25,98k | -1,91% |
| 2026-02-23 | Mr. Douglas E. ColtharpExec. VP & CFO | -14,82k | 1,57M | Sale to Issuer | 106,15 | 261,01k | -5,37% |
| 2026-02-23 | Mr. Andrew L. PriceSenior VP & CAO | -404,00 | 42,88k | Sale to Issuer | 106,15 | 75,00k | -0,54% |
| 2026-02-23 | Dr. Elissa Joy CharbonneauChief Medical Officer | -440,00 | 46,71k | Sale to Issuer | 106,15 | 18,01k | -2,38% |
| 2026-02-23 | Mr. John Patrick DarbyExec. VP, General Counsel & Corporate Secretary | -6,99k | 741,99k | Sale to Issuer | 106,15 | 84,36k | -7,65% |
| 2026-02-19 | Dr. Elissa Joy CharbonneauChief Medical Officer | -4,30k | 460,89k | Sale to Issuer | 106,55 - 107,15 | 18,45k | -18,91% |
| 2026-02-19 | Mr. Mark J. TarrCEO, President & Director | -45,18k | 4,84M | Sale to Issuer | 106,55 - 107,15 | 445,64k | -9,20% |
| 2026-02-19 | Mr. Edmund M. FaySenior VP & Treasurer | -3,69k | 394,94k | Sale to Issuer | 106,55 - 107,15 | 101,92k | -3,49% |
| 2026-02-19 | Mr. Andrew L. PriceSenior VP & CAO | -3,92k | 419,89k | Sale to Issuer | 106,55 - 107,15 | 75,41k | -4,94% |
| 2026-02-19 | Mr. John Patrick DarbyExec. VP, General Counsel & Corporate Secretary | -8,23k | 881,75k | Sale to Issuer | 106,55 - 107,15 | 91,35k | -8,27% |
| 2026-02-19 | Mr. Douglas E. ColtharpExec. VP & CFO | -17,38k | 1,86M | Sale to Issuer | 106,55 - 107,15 | 275,83k | -5,93% |
| 2026-02-19 | Mr. Patrick W. TuerExec. VP & COO | -3,60k | 385,28k | Sale to Issuer | 106,55 - 107,15 | 26,49k | -11,96% |
| 2026-02-11 | Mr. Mark J. TarrCEO, President & Director | -150,00k | 16,75M | Vendita | 108,03 - 113,58 | 377,07k | -28,46% |
| 2026-02-10 | Mr. Patrick W. TuerExec. VP & COO | -2,80k | 301,77k | Vendita | 107,62 | 16,04k | -14,88% |
| 2025-08-27 | Mr. Patrick W. TuerExec. VP & COO | -1,02k | 126,06k | Vendita | 123,59 | 18,85k | -5,13% |
| 2025-08-21 | Mr. Douglas E. ColtharpExec. VP & CFO | -27,48k | 0,00 | Other Disposition | - | 251,20k | -9,86% |
Le azioni che visualizzerai appariranno in questo riquadro, così potrai facilmente tornare alle quotazioni di tuo interesse.
Assistenza: support@advfn.it
Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni
Registrati con e-mail
Hai già un account? Accedi
Non hai un account? Registrati
Registrandomi, confermo di aver letto, capito, e accetto i termini e condizioni ADVFN e che sono un investitore privato.
Caratteristiche principali
Premium
